- Home
- AEHL vs EDSA Comparison
AEHL vs EDSA Comparison
Compare AEHL & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEHL
- EDSA
- Stock Information
- Founded
- AEHL 1993
- EDSA 2015
- Country
- AEHL China
- EDSA Canada
- Employees
- AEHL N/A
- EDSA N/A
- Industry
- AEHL Building Materials
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- AEHL Industrials
- EDSA Health Care
- Exchange
- AEHL Nasdaq
- EDSA Nasdaq
- Market Cap
- AEHL 17.3M
- EDSA 18.6M
- IPO Year
- AEHL 2007
- EDSA N/A
- Fundamental
- Price
- AEHL $1.67
- EDSA $1.75
- Analyst Decision
- AEHL
- EDSA Strong Buy
- Analyst Count
- AEHL 0
- EDSA 2
- Target Price
- AEHL N/A
- EDSA $13.00
- AVG Volume (30 Days)
- AEHL 414.9K
- EDSA 906.5K
- Earning Date
- AEHL 12-26-2025
- EDSA 12-12-2025
- Dividend Yield
- AEHL N/A
- EDSA N/A
- EPS Growth
- AEHL N/A
- EDSA N/A
- EPS
- AEHL N/A
- EDSA N/A
- Revenue
- AEHL $98,773,000.00
- EDSA N/A
- Revenue This Year
- AEHL N/A
- EDSA N/A
- Revenue Next Year
- AEHL N/A
- EDSA N/A
- P/E Ratio
- AEHL N/A
- EDSA N/A
- Revenue Growth
- AEHL 36.99
- EDSA N/A
- 52 Week Low
- AEHL $1.40
- EDSA $1.55
- 52 Week High
- AEHL $13.06
- EDSA $4.49
- Technical
- Relative Strength Index (RSI)
- AEHL 31.63
- EDSA 31.73
- Support Level
- AEHL $1.78
- EDSA $1.90
- Resistance Level
- AEHL $2.19
- EDSA $2.02
- Average True Range (ATR)
- AEHL 0.32
- EDSA 0.21
- MACD
- AEHL -0.10
- EDSA -0.08
- Stochastic Oscillator
- AEHL 15.43
- EDSA 7.68
About AEHL Antelope Enterprise Holdings Limited
Antelope Enterprise Holdings Ltd operates in two reportable operating segments: 1) business management consulting, information system technology consulting services including the sales of software use rights for digital data deposit platforms and asset management systems, and online social media platform development and consulting, and 2) natural gas power generation, which was in the initial development stage. The business of the Company is engaged in the PRC and U.S.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.